EGLN3 and central nervous system cancer: PHD3 expression is frequently attenuated in high-grade gliomas (Henze et al., 2014), and we hypothesized that re-expression of the active PHD3 may stabilize p53 and impede cell proliferation and apoptosis in cell lines where PHD3 is silenced.